Pro-inflammatory action of LDL(-) on mononuclear cells is counteracted by increased IL10 production

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1771, Issue 5, 2007, Pages 613-622

  Benítez, Sònia ^a   Bancells, Cristina ^a   Ordóñez Llanos, Jordi ^a,b   Sánchez Quesada, Jose Luis ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Cytokine; IL10; LDL( ); Lymphocyte; Monocyte

Indexed keywords

DACTINOMYCIN; INTERLEUKIN 10; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; POLYMYXIN B;

ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LEUKOCYTE; LYMPHOCYTE; MONOCYTE; MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CYTOKINES; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; LIPOPROTEINS, LDL; LYMPHOCYTES; MONOCYTES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 34247640096     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2007.03.001     Document Type: Article

References (49)

1. Pentikainen M.O., Oorni K., Ala-Korpela M., and Kovanen P.T. Modified LDL - Trigger of atherosclerosis and inflammation in the arterial intima. J. Intern. Med. 247 (2000) 359-370
2. Sanchez-Quesada J.L., Benitez S., and Ordonez-Llanos J. Electronegative low-density lipoprotein. Curr. Opin. Lipidol. 15 (2004) 329-335
3. Sanchez-Quesada J.L., Perez A., Caixas A., Ordonmez-Llanos J., Carreras G., Payes A., Gonzalez-Sastre F., and de Leiva A. Electronegative low density lipoprotein subform is increased in patients with short-duration IDDM and is closely related to glycaemic control. Diabetologia 39 (1996) 1469-1476
4. Sanchez-Quesada J.L., Otal-Entraigas C., Franco M., Jorba O., Gonzalez-Sastre F., Blanco-Vaca F., and Ordonez-Llanos J. Effect of simvastatin treatment on the electronegative low-density lipoprotein present in patients with heterozygous familial hypercholesterolemia. Am. J. Cardiol. 84 (1999) 655-659
5. Sanchez-Quesada J.L., Perez A., Caixas A., Rigla M., Payes A., Benitez S., and Ordonez-Llanos J. Effect of glycemic optimization on electronegative low-density lipoprotein in diabetes: relation to nonenzymatic glycosylation and oxidative modification. J. Clin. Endocrinol. Metab. 86 (2001) 3243-3249
6. De Castellarnau C., Sanchez-Quesada J.L., Benitez S., Rosa R., Caveda L., Vila L., and Ordonez-Llanos J. Electronegative LDL from normolipemic subjects induces IL-8 and monocyte chemotactic protein secretion by human endothelial cells. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 2281-2287
7. Benitez S., Camacho M., Bancells C., Vila L., Sanchez-Quesada J.L., and Ordonez-Llanos J. Wide proinflammatory effect of electronegative low-density lipoprotein on human endothelial cells assayed by a protein membrane assay. Biochim. Biophys. Acta 1761 (2006) 1014-1021
8. Sanchez-Quesada J.L., Camacho M., Anton R., Benitez S., Vila L., and Ordonez-Llanos J. Electronegative LDL of FH subjects: chemical characterization and induction of chemokine release from human endothelial cells. Atherosclerosis 166 (2003) 261-270
9. Castellarnau C., Bancells C., Benitez S., Ordoñez-Llanos J., and Sanchez-Quesada J.L. Atherogenic and inflammatory profile of human arterial endothelial cells (HUAEC) in response to LDL fractions. Clim. Chem. Acta 376 (2007) 233-236
10. Demuth K., Myara I., Chappey B., Vedie B., Pech-Amsellem M.A., Haberland M.E., and Moatti N. A cytotoxic electronegative LDL subfraction is present in human plasma. Arterioscler. Thromb. Vasc. Biol. 16 (1996) 773-783
11. Hodis H.N., Kramsch D.M., Avogaro P., Bittolo-Bon G., Cazzolato G., Hwang J., Peterson H., and Sevanian A. Biochemical and cytotoxic characteristics of an in vivo circulating oxidized low density lipoprotein (LDL-). J. Lipid. Res. 35 (1994) 669-677
12. Chen C.H., Jiang T., Yang J.H., Jiang W., Lu J., Marathe G.K., Pownall H.J., Ballantyne C.M., McIntyre T.M., Henry P.D., and Yang C.Y. Low-density lipoprotein in hypercholesterolemic human plasma induces vascular endothelial cell apoptosis by inhibiting fibroblast growth factor 2 transcription. Circulation 107 (2003) 2102-2108
13. Osterud B., and Bjorklid E. Role of monocytes in atherogenesis. Physiol. Rev. 83 (2003) 1069-1112
14. Pinderski Oslund L.J., Hedrick C.C., Olvera T., Hagenbaugh A., Territo M., Berliner J.A., and Fyfe A.I. Interleukin-10 blocks atherosclerotic events in vitro and in vivo. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 2847-2853
15. Mallat Z., Besnard S., Duriez M., Deleuze V., Emmanuel F., Bureau M.F., Soubrier F., Esposito B., Duez H., Fievet C., Staels B., Duverger N., Scherman D., and Tedgui A. Protective role of interleukin-10 in atherosclerosis. Circ. Res. 85 (1999) e17-e24
16. Moore K.W., de Waal Malefyt R., Coffman R.L., and O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19 (2001) 683-765
17. de Waal Malefyt R., Abrams J., Bennett B., Figdor C.G., and de Vries J.E. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174 (1991) 1209-1220
18. de Waal Malefyt R., Yssel H., and de Vries J.E. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J. Immunol. 150 (1993) 4754-4765
19. Fiorentino D.F., Zlotnik A., Mosmann T.R., Howard M., and O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147 (1991) 3815-3822
20. Wang P., Wu P., Anthes J.C., Siegel M.I., Egan R.W., and Billah M.M. Interleukin-10 inhibits interleukin-8 production in human neutrophils. Blood 83 (1994) 2678-2683
21. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand. J. Clin. Lab. Invest., Suppl. 97 (1968) 77-89
22. Vanderlaan P.A., and Reardon C.A. Thematic review series: the immune system and atherogenesis. The unusual suspects: an overview of the minor leukocyte populations in atherosclerosis. J. Lipid. Res. 46 (2005) 829-838
23. Benitez S., Perez A., Sanchez-Quesada J.L., Wagner A.M., Rigla M., Arcelus R., Jorba O., and Ordonez-Llanos J. Electronegative low-density lipoprotein subfraction from type 2 diabetic subjects is proatherogenic and unrelated to glycemic control. Diabetes Metab. Res. Rev. 23 (2007) 26-34
24. Heeschen C., Dimmeler S., Hamm C.W., Fichtlscherer S., Boersma E., Simoons M.L., and Zeiher A.M. Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 107 (2003) 2109-2114
25. Mizia-Stec K., Gasior Z., Zahorska-Markiewicz B., Janowska J., Szulc A., Jastrzebska-Maj E., and Kobielusz-Gembala I. Serum tumour necrosis factor-alpha, interleukin-2 and interleukin-10 activation in stable angina and acute coronary syndromes. Coron. Artery Dis. 14 (2003) 431-438
26. Mallat Z., Heymes C., Ohan J., Faggin E., Leseche G., and Tedgui A. Expression of interleukin-10 in advanced human atherosclerotic plaques: relation to inducible nitric oxide synthase expression and cell death. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 611-616
27. Mizia-Stec K., Zahorska-Markiewicz B., Mandecki T., Janowska J., Szulc A., Jastrzekbska-Maj E., and Gasior Z. Hyperlipidaemias and serum cytokines in patients with coronary artery disease. Acta Cardiol. 58 (2003) 9-15
28. Mysliwska J., Zorena K., Semetkowska-Jurkiewicz E., Rachon D., Suchanek H., and Mysliwski A. High levels of circulating interleukin-10 in diabetic nephropathy patients. Eur. Cytokine Netw. 16 (2005) 117-122
29. Liu Y., Li D., Chen J., Xie J., Bandyopadhyay S., Zhang D., Nemarkommula A.R., Liu H., Mehta J.L., and Hermonat P.L. Inhibition of atherogenesis in LDLR knockout mice by systemic delivery of adeno-associated virus type 2-hIL-10. Atherosclerosis (2005)
30. Ajuebor M.N., Das A.M., Virag L., Szabo C., and Perretti M. Regulation of macrophage inflammatory protein-1 alpha expression and function by endogenous interleukin-10 in a model of acute inflammation. Biochem. Biophys. Res. Commun. 255 (1999) 279-282
31. Potteaux S., Esposito B., van Oostrom O., Brun V., Ardouin P., Groux H., Tedgui A., and Mallat Z. Leukocyte-derived interleukin 10 is required for protection against atherosclerosis in low-density lipoprotein receptor knockout mice. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 1474-1478
32. Kuhn R., Lohler J., Rennick D., Rajewsky K., and Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75 (1993) 263-274
33. Asadullah K., Sterry W., and Volk H.D. Interleukin-10 therapy-review of a new approach. Pharmacol. Rev. 55 (2003) 241-269
34. Uyemura K., Demer L.L., Castle S.C., Jullien D., Berliner J.A., Gately M.K., Warrier R.R., Pham N., Fogelman A.M., and Modlin R.L. Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. J. Clin. Invest. 97 (1996) 2130-2138
35. Rubic T., and Lorenz R.L. Downregulated CD36 and oxLDL uptake and stimulated ABCA1/G1 and cholesterol efflux as anti-atherosclerotic mechanisms of interleukin-10. Cardiovasc. Res. 69 (2006) 527-535
36. Arai T., Hiromatsu K., Nishimura H., Kimura Y., Kobayashi N., Ishida H., Nimura Y., and Yoshikai Y. Endogenous interleukin 10 prevents apoptosis in macrophages during Salmonella infection. Biochem. Biophys. Res. Commun. 213 (1995) 600-607
37. Cohen S.B., Crawley J.B., Kahan M.C., Feldmann M., and Foxwell B.M. Interleukin-10 rescues T cells from apoptotic cell death: association with an upregulation of Bcl-2. Immunology 92 (1997) 1-5
38. Capsoni F., Minonzio F., Mariani C., Ongari A.M., Bonara P., and Fiorelli G. Development of phagocytic function of cultured human monocytes is regulated by cell surface IL-10. Cell. Immunol. 189 (1998) 51-59
39. Vestergaard C., Gesser B., Lohse N., Jensen S.L., Sindet-Pedersen S., Thestrup-Pedersen K., Matsushima K., and Larsen C.G. Monocyte chemotactic and activating factor (MCAF/MCP-1) has an autoinductive effect in monocytes, a process regulated by IL-10. J. Dermatol. Sci. 15 (1997) 14-22
40. Gesser B., Deleuran B., Lund M., Vestergard C., Lohse N., Deleuran M., Jensen S.L., Pedersen S.S., Thestrup-Pedersen K., and Larsen C.G. Interleukin-8 induces its own production in CD4+ T lymphocytes: a process regulated by interleukin 10. Biochem. Biophys. Res. Commun. 210 (1995) 660-669
41. Wang P., Wu P., Siegel M.I., Egan R.W., and Billah M.M. IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J. Immunol. 153 (1994) 811-816
42. Knolle P.A., Uhrig A., Protzer U., Trippler M., Duchmann R., Meyer zum Buschenfelde K.H., and Gerken G. Interleukin-10 expression is autoregulated at the transcriptional level in human and murine Kupffer cells. Hepatology 27 (1998) 93-99
43. O'Garra A., Vieira P.L., Vieira P., and Goldfeld A.E. IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage. J. Clin. Invest. 114 (2004) 1372-1378
44. Suttles J., Milhorn D.M., Miller R.W., Poe J.C., Wahl L.M., and Stout R.D. CD40 signaling of monocyte inflammatory cytokine synthesis through an ERK1/2-dependent pathway. A target of interleukin (il)-4 and il-10 anti-inflammatory action. J. Biol. Chem. 274 (1999) 5835-5842
45. Sato K., Nagayama H., Tadokoro K., Juji T., and Takahashi T.A. Extracellular signal-regulated kinase, stress-activated protein kinase/c-Jun N-terminal kinase, and p38mapk are involved in IL-10-mediated selective repression of TNF-alpha-induced activation and maturation of human peripheral blood monocyte-derived dendritic cells. J. Immunol. 162 (1999) 3865-3872
46. Ricchetti G.A., Williams L.M., and Foxwell B.M. Heme oxygenase 1 expression induced by IL-10 requires STAT-3 and phosphoinositol-3 kinase and is inhibited by lipopolysaccharide. J. Leukoc. Biol. 76 (2004) 719-726
47. Driessler F., Venstrom K., Sabat R., Asadullah K., and Schottelius A.J. Molecular mechanisms of interleukin-10-mediated inhibition of NF-kappaB activity: a role for p50. Clin. Exp. Immunol. 135 (2004) 64-73
48. Rahimi A.A., Gee K., Mishra S., Lim W., and Kumar A. STAT-1 mediates the stimulatory effect of IL-10 on CD14 expression in human monocytic cells. J. Immunol. 174 (2005) 7823-7832
49. Giambartolomei G.H., Dennis V.A., Lasater B.L., Murthy P.K., and Philipp M.T. Autocrine and exocrine regulation of interleukin-10 production in THP-1 cells stimulated with Borrelia burgdorferi lipoproteins. Infect. Immun. 70 (2002) 1881-1888